Florine A. Eggink

<i>POLE</i> Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills et al. · Clinical Cancer Research · 2015 · 307 citations · Full text

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

Hagma H. Workel, Joyce M. Lubbers, Roland Arnold et al. · Cancer Immunology Research · 2019 · 249 citations · Full text

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

Hagma H. Workel, Fenne L. Komdeur, Maartje C.A. Wouters et al. · European Journal of Cancer · 2016 · 137 citations · Full text

Endometrial Adenocarcinoma, Cancer Immunosurveillance, Oncology +8

Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Florine A. Eggink, Inge C. van Gool, Alexandra Léary et al. · OncoImmunology · 2016 · 119 citations · Full text

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy

Fenne L. Komdeur, Maartje C.A. Wouters, Hagma H. Workel et al. · Oncotarget · 2016 · 68 citations · Full text

Checkpoint Inhibition, Lymphocyte Development, T-regulatory Cell +23